Toward appropriate criteria in medication adherence assessment in older persons: Position Paper

Aging Clinical and Experimental Research

Volumn 28, Issue 3, 2016, Pages 371-381

  Giardini, Anna ^a   Martin, Maria Teresa ^b   Cahir, Caitriona ^c,d   Lehane, Elaine ^e   Menditto, Enrica ^f   Strano, Maria ^g   Pecorelli, Sergio ^h,i   Monaco, Alessandro ^h   Marengoni, Alessandra ^h,i  

^a IRCCS   (Italy)

^b HOSPITAL CLÍNIC   (Spain)

^c ECONOMIC AND SOCIAL RESEARCH INSTITUTE   (Ireland)

^d ST JAMES S HOSPITAL   (Ireland)

^e UNIVERSITY COLLEGE CORK   (Ireland)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g Medical Department   (Italy)

^h ITALIAN MEDICINES AGENCY   (Italy)

ⁱ UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Adherence; Chronic diseases; Elderly; Nonadherence; Polypharmacy; Tools

Indexed keywords

AGED; CLINICAL ASSESSMENT; DRUG MONITORING; ELECTRONIC MONITORING DEVICE; HUMAN; MEDICAL DEVICE; MEDICAL RECORD; MEDICATION COMPLIANCE; MEDICATION EVENT MONITORING SYSTEM; PHARMACEUTICAL CARE; PHARMACY CLAIM; PILL COUNT; POLYPHARMACY; REVIEW; SELF REPORT; DRUG DATABASE; DRUG SURVEILLANCE PROGRAM; ELDERLY CARE; GERIATRIC ASSESSMENT; PROCEDURES; PSYCHOLOGY; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; DATABASES, PHARMACEUTICAL; DRUG MONITORING; GERIATRIC ASSESSMENT; HEALTH SERVICES FOR THE AGED; HUMANS; MEDICATION ADHERENCE; REPRODUCIBILITY OF RESULTS;

EID: 84973901348     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-015-0435-z     Document Type: Review

References (54)

1. World Health Organisation (2003) Adherence to long-term therapies: evidence for action. World Health Organisation, Geneva
2. Sabate E (ed) (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva
3. Gottlieb H (2000) Medication nonadherence- finding solutions to a costly medical problem. Drug Benefit Trends 12:57–62
4. Budnitz DS, Lovegrove MC, Shehab N et al (2011) Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 365:2002–2012
5. Howard RL, Avery AJ, Slavenburg S et al (2007) Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 63:136–147
6. Gurwitz JH, Field TS, Harrold LR, Rothschild J et al (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. J Am Med Assoc 289:1107–1116
7. Horne R (2001) Compliance, adherence and concordance. In: Taylor K (ed) Pharmacy practice. Taylor and Francis, London, pp 165–184
8. Balkrishnan R, Jayawant SS (2007) Medication adherence research in populations: measurement issues and other challenges. Clin Ther 29:1180–1183
9. van Dulmen S, Sluijs E, van Dijk L, de Ridder D et al (2007) Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res 7:55
10. Shemesh E (2008) Adherence to medical regimens. In: Kleinman RE, Goulet OJ, Mieli-Vergani G, Sanderson IR, Sherman PM, Shneider BL (eds) Walker’s pediatric gastrointestinal disease, 5th ed, vol 2. BC Decker Inc., Ontario
11. Lieber SR, Helcer J, Shemesh E (2014) Monitoring drug adherence. Transplant Rev (Orlando). doi:10.1016/j.trre.2014.10.001
12. Nguyen TM, La Caze A, Cottrell N (2014) What are validated self-report adherence scales really measuring? A systematic review. Br J Clin Pharmacol 277:427–445
13. Cheng CW, Woo KS, Chan JC et al (2005) Assessing adherence to statin therapy using patient report, pill-count, and an electronic monitoring device. Am J Health Syst Pharm 62:411–415
14. Schroeder K, Fahey T, Hay A et al (2006) Adherence to anti-hypertensive medication assessed by self-report was associated with electronic monitoring compliance. J Clin Epidemiol 59:650–651
15. Shi L, Liu J, Fonseca V et al (2010) Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes 13:99
16. Farmer KC (1999) Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21:1074–1790
17. Garfield S, Clifford S, Eliasson L et al (2011) Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol 11:149
18. Giardini A, Pierobon A, Majani G et al (2011) Adherence self report assessment in solid-organ pre and post transplant recipients. G Ital Med Lav Ergon 33:A69–A76
19. DeVellis R (2012) Scale development: theory and applications (Applied Social Research Methods), 3rd edn. Sage Publications, Los Angeles
20. Vik SA, Maxwell CJ, Hogan DB et al (2005) Assessing medication adherence among older persons in community setting. Can J Clin Pharmacol 12:e152–e164
21. Botelho RJ, Dudrak R (1992) Home assessment of adherence to long-term medication in the elderly. J Fam Pract 35:61–65
22. Grymonpre RE, Didur CD, Montgomery PR et al (1998) Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 32:749–754
23. Nieuwenhuis MM, Jaarsma T, van Veldhuisen DJ et al (2012) Self-reported versus ‘true’ adherence in heart failure patients: a study using the medication event monitoring system. Neth Heart J 20:313–319
24. Wu JR, Moser DK, Chung ML et al (2008) Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail 14:203–210
25. Zeller A, Ramseier E, Teagtmeyer A et al (2008) Patients’ self-reported adherence to cardiovascular medication using electronic monitors as comparators. Hypertens Res 31:2037–2043
26. Dunbar-Jacob J, Sereika SM, Houze M et al (2012) Accuracy of measures of medication adherence in a cholesterol-lowering regimen. West J Nurs Res 34:578–597
27. Diaz E, Levine HB, Sullivan MC et al (2001) Use of the medication event monitoring system to estimate medication compliance in patients with schizophrenia. J Psychiatry Neurosci 26:325–329
28. Deschamps AE, Graeve VD, van Wijngaerden E et al (2004) Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using a medication event monitoring system. AIDS Patient Care STDS 18:644–657
29. Krummenacher I, Cavassini M, Bugnon O et al (2011) An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS Care 23:550–561
30. Deschamps AE, De Geest S, Vandamme AM et al (2008) Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS 22:735–743
31. Wetzels GE, Nelemans PJ, Schouten JS et al (2007) Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial. Am J Hypertens 20:119–125
32. Santschi V, Rodondi N, Bugnon O et al (2008) Impact of electronic monitoring of drug adherence on blood pressure control in primary care: a cluster 12-month randomised controlled study. Eur J Intern Med 19:427–434
33. van Onzenoort HA, Verberk WJ, Kroon AA et al (2012) Electronic monitoring of adherence, treatment of hypertension, and blood pressure control. Am J Hypertens 25:54–59
34. Deschamps AE, Van Wijngaerden E, Denhaerynck K et al (2006) Use of electronic monitoring induces a 40-day intervention effect in HIV patients. J Acquir Immune Defic Syndr 43:247–248
35. Lehmann A, Aslani P, Ahmed R et al (2014) Assessing medication adherence: options to consider. Int J Clin Pharm 36:55–69
36. Kang Ju-Seop, Lee Min-Ho (2009) Overview of therapeutic drug monitoring. Korean J Intern Med 24:1–10
37. Jung O, Gechter JL, Wunder C et al (2013) Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens 31:766–774
38. Ceral J, Habrdova V, Vorisek V et al (2011) Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate nonresponsiveness from nonadherence to recommended therapy. Hypertens Res 34:87–90
39. Lim LL (1992) Estimating compliance to study medication from serum drug levels: application to an AIDS clinical trial of zidovudine. Biometrics 48:619–630
40. Serebruany V, Malinin A, Dragan V et al (2007) Fluorimetric quantitation of citalopram and escitalopram in plasma: developing an express method to monitor compliance in clinical trials. Clin Chem Lab Med 45:513–520
41. Mani H, Toennes SW, Linnemann B et al (2008) Determination of clopidogrel main metabolite in plasma: a useful tool for monitoring therapy? Ther Drug Monit 30:84–89
42. Schafer-Kellera P, Steiger J, Bock A et al (2008) Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant 8:616–626
43. Widmer N, Bardin C, Chatelut E et al (2014) Review of therapeutic drug monitoring of anticancer drugs part two—targeted therapies. Eur J Cancer 50:2020–2036
44. Poluzzi E, Strahinja P, Vaccheri A et al (2007) Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. Br J Clin Pharmacol 63:346–355
45. Mazzaglia G, Ambrosioni E, Alacqua M et al (2009) Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 120:1598–1605
46. Citarella A, Kieler H, Sundström A et al (2014) Family history of cardiovascular disease and influence on statin therapy persistence. Eur J Clin Pharmacol 70:701–707
47. Casula M, Catapano AL, Piccinelli R et al (2014) Assessment and potential determinants of compliance and persistence to antiosteoporosis therapy in Italy. Am J Manag Care 20:e138–e145
48. Lapi F, Lucenteforte E, Moschini M et al (2013) Representativeness of the “Fiesole Misurata” study database for use in pharmaco-epidemiological investigations on adherence to antihypertensive medications. Aging Clin Exp Res 25:433–445
49. Andrade SE, Kahler KH, Frech F et al (2006) Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15:565–574
50. Berg KM, Arnsten JH (2006) Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr 43:S79–S87
51. Cramer JA, Roy A, Burrell A et al (2008) Medication compliance and persistence: terminology and definitions. Value Health 11:44–47
52. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487–497
53. Marengoni A, Angleman S, Melis R et al (2011) Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev 10:430–439
54. Onder G, Bonassi S, Abbatecola AM et al (2014) High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA). J Gerontol A Biol Sci Med Sci 69:430–437